Suppr超能文献

最常见的氨基糖苷类耐药机制——全球八个地区调查的综合结果。氨基糖苷类耐药性研究小组。

The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.

出版信息

J Chemother. 1995 Jun;7 Suppl 2:17-30.

PMID:8622108
Abstract

Aminoglycoside-resistant isolates from different patients were collected in 149 hospitals in eight regions of the world. Aminoglycoside resistance mechanisms were determined in 11,079 of these isolates by the correlation of resistance phenotypes to 12 aminoglycosides and DNA hybridisation with up to 19 resistance genes. A very large diversity of different resistance mechanisms was found. For example, in Escherichia-Morganella-Proteus-Salmonella-Shigella, at total of 53 different mechanisms was found among the 2080 isolates studied. Therefore, the most common resistance mechanisms in the seven different pathogen groups were summarised. The seven pathogen groups were chosen so that each one had a unique mixture of resistance mechanisms. Among Enterobacteriaceae, the Citrobacter-Enterobacter-Klebsiella, Providencia and Serratia groups had a particularly high incidence of combinations of resistance mechanisms especially when compared with data from eight early surveys. These mechanisms often tended to be combinations of previously common gentamicin-modifying enzymes with AAC(6')-I, an enzyme which can acetylate tobramycin, netilmicin and amikacin but which does not usually cause resistance to isepamicin. Resistance rates among the four Enterobacteriaceae groups reflected the incidence of these combinations; that is, amikacin resistance was 43.1%, 21.7%, 4.2% and 37.6% while that to isepamicin was 9.9%, 9.7% 2.7% and 7.6%, respectively. A very large diversity of mechanisms was found in Pseudomonas. However, three mechanism - permeability, ACC(6')-II and ANT(2")-I - were very common, both alone as single mechanisms and in combination with each other or other mechanisms. Because of the high incidence of permeability resistance in Pseudomonas, resistance to all aminoglycosides was quite high and the difference between amikacin (41.7%) and isepamicin (36.8%) was smaller. The greatest diversity of resistance mechanisms (67 in 1189 isolates) was found in Acinetobacter. The most common mechanisms - APH(3')-VI and AAC(3)-? - were generally very rare in other genera but found frequently in Acinetobacter in combinations with a wide variety of other mechanisms. The most frequent resistance mechanisms in Acinetobacter varied by geographic region much more than did mechanisms in other genera. The resistance rates to all of the clinically useful aminoglycosides were generally higher in Acinetobacter than in any other pathogen group. In contrast to the other pathogen groups, only seven resistance mechanisms were found in the 898 resistant Staphylococcus. These were composed of the three known single mechanisms and four combinations of these three mechanisms. Because the principal resistance mechanism, (APH(2") + ACC(6'), confers high-level resistance to gentamicin and tobramycin and a lower level of resistance to amikacin, isepamicin and netilmicin, the observed resistance rate to netilmicin (15.0%) was the lowest for any of the aminoglycosides.

摘要

来自世界各地八个地区149家医院的不同患者的耐氨基糖苷类分离株被收集。通过将耐药表型与12种氨基糖苷类药物进行相关性分析以及与多达19个耐药基因进行DNA杂交,在其中11079株分离株中确定了氨基糖苷类耐药机制。发现了非常多样的不同耐药机制。例如,在大肠埃希菌-摩根菌-变形杆菌-沙门菌-志贺菌中,在所研究的2080株分离株中总共发现了53种不同机制。因此,总结了七个不同病原体组中最常见的耐药机制。选择这七个病原体组是为了使每个组都有独特的耐药机制组合。在肠杆菌科中,柠檬酸杆菌-肠杆菌-克雷伯菌、普罗威登斯菌和沙雷菌组耐药机制组合的发生率特别高,尤其是与八项早期调查的数据相比。这些机制往往是以前常见的庆大霉素修饰酶与AAC(6')-I的组合,AAC(6')-I是一种可以使妥布霉素、奈替米星和阿米卡星乙酰化,但通常不会导致对异帕米星耐药的酶。四个肠杆菌科组中的耐药率反映了这些组合的发生率;也就是说,对阿米卡星的耐药率分别为43.1%、21.7%、4.2%和37.6%,而对异帕米星的耐药率分别为9.9%、9.7%、2.7%和7.6%。在假单胞菌中发现了非常多样的机制。然而,三种机制——通透性、ACC(6')-II和ANT(2")-I——非常常见,既单独作为单一机制,也相互组合或与其他机制组合。由于假单胞菌中通透性耐药的发生率很高,对所有氨基糖苷类药物的耐药性都相当高,阿米卡星(41.7%)和异帕米星(36.8%)之间的差异较小。在不动杆菌中发现了最多样化的耐药机制(1189株分离株中有67种)。最常见的机制——APH(3')-VI和AAC(3)-?——在其他属中通常非常罕见,但在不动杆菌中经常与多种其他机制组合出现。不动杆菌中最常见的耐药机制因地理区域而异的程度比其他属中的机制大得多。不动杆菌对所有临床有用的氨基糖苷类药物的耐药率通常高于任何其他病原体组。与其他病原体组不同,在898株耐药葡萄球菌中仅发现了七种耐药机制。这些由三种已知的单一机制以及这三种机制的四种组合组成。由于主要耐药机制(APH(2") + ACC(6'))赋予对庆大霉素和妥布霉素高水平耐药,对阿米卡星、异帕米星和奈替米星低水平耐药,观察到的对奈替米星的耐药率(15.0%)是所有氨基糖苷类药物中最低的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验